• Japanese
  • Korean
  • Chinese
Cover Image

European Alzheimer's Disease Medication Market

Abstract

Launch of Disease-modifying Drugs expected to Boost Market Growth

The key objective of this research service is to study the European Alzheimer's disease medication market based on the three major classes of drugs namely acetylcholinesterase inhibitors, NMDA receptor antagonists and new mechanism/ disease modifying drugs and identify the key current and future trends shaping these market segments. It also aims to provide valuable insights on the potential drug candidates in the pipeline and analyse the competitive landscape with respect to the key existing market participants and promising companies in the future. Revenue forecasts of total market as well as key five European countries is also provided.

Key Questions This Study Will Answer

  • Is the market growing, how long will it continue to grow and at what rate?
  • What are the potential drug candidates in pipeline and the key blockbuster drugs likely to lose patent protection during the forecast period?
  • Who are the current active participants in the European AD medication market and the promising companies in the future?
  • How will the structure of the market change over time? What are the key future trends and their impact on the market?
  • Are the products/services offered today meeting customer needs or is there still scope for additional development?
  • Are the regulatory guidelines well structured to favour the cause of innovator and generic companies? What are the annual costs of dementia incurred by the European Governments?

Table of Contents

1. European Alzheimer's Disease Medication Market

Executive Summary

  • Executive Summary

Market Overview

  • Market Overview-Definitions
  • Market Overview - Key Questions This Study Will Answer
  • Market Overview
  • Key Timeline of Events
  • Central Nervous System (CNS) Disorder Segmentation
  • Market Segmentation
  • Market Overview - Segmentation
  • Geographic Scope
  • Geographic Segmentation

Introduction to Alzheimer's Disease

  • Disease Overview
  • Pathophysiology
  • Disease Staging
  • Risk Factors
  • Diagnosis
  • Key Areas of R&D

Epidemiology

  • Dementia Prevalence
  • Dementia Patients - Forecasts
  • Treatment Statistics

External Challenges: Drivers and Restraints - Total Alzheimer's Disease Medication Market

  • Market Drivers and Restraints
  • Market Drivers - Explained
  • Market Restraints - Explained
  • Impact Mapping of Drivers and Restraints

Revenue Forecast - Total Alzheimer's Disease Medication Market

  • European Alzheimer's Disease Medication Market - Market Engineering Measurements
  • Forecast Assumptions
  • European Alzheimer's Disease Medication Market - Revenue Forecast
  • European Alzheimer's Disease Medication Market - Revenue Forecast Discussion

Market Share and Competitive Analysis - Total Alzheimer's Disease Medication Market

  • Competitive Analysis - Market Share
  • Market Share Analysis
  • Competitive Environment
  • Competitive Analysis: Profiling of Selected Key Market Participants
  • Competitive Analysis: Most Promising Companies in the Future
  • Top Competitors
  • Competitor Growth Analysis
  • Alzheimer's Disease Medication Market Competitive Landscape

Marketed Product Analysis

  • EMEA Approved Drugs for Alzheimer's Disease
  • Aricept
  • Exelon/ Exelon Patch
  • Reminyl
  • Ebixa
  • Dosing Regimen

Pipeline Analysis

  • Pipeline Overview
  • Pipeline Analysis by Clinical Phase
  • Pipeline Analysis by Mechanism of Action
  • Key Pipeline Drug Candidates by Mechanism of Action
  • Promising Late-stage Drug Candidates
  • Late-stage Failed Drug Candidates

Cost Analysis and Disease Burden

  • Costs of Dementia
  • Costs of Dementia - Forecast
  • Cost Analysis
  • Disease Burden

Regulatory Analysis

  • The European Union Regulatory Framework for Alzheimer's Disease
  • Diagnostic Criteria
  • Therapeutic Efficacy Criteria
  • Measurement Tools
  • General Strategy
  • Geriatric Requirements

Acetylcholinesterase Inhibitors Segment Breakdown

  • Acetylcholinesterase Inhibitors Overview
  • Acetylcholinesterase Inhibitors Mechanism of Action
  • Market Engineering Measurements
  • Revenue Forecast
  • Revenue Forecast Discussion
  • End-user Analysis
  • Physician's Perception

NMDA Receptor Antagonists Segment Breakdown

  • NMDA Receptor Antagonists Overview
  • NMDA Receptor Antagonists Mechanism of Action
  • Market Engineering Measurements
  • Revenue Forecast
  • Revenue Forecast Discussion
  • End-user Analysis
  • Physician's Perception

Disease-modifying Drugs Segment Breakdown

  • Disease-modifying Drugs Overview
  • Disease-modifying Drugs Mechanism of Action
  • Market Engineering Measurements
  • Revenue Forecast
  • Revenue Forecast Discussion

German Alzheimer's Disease Medication Market

  • Germany-Market Engineering Measurements
  • Germany-Revenue Forecast
  • Regulatory Framework - Treatment Access and Reimbursement of Drugs

French Alzheimer's Disease Medication Market

  • France-Market Engineering Measurements
  • France-Revenue Forecast
  • Regulatory Framework - Treatment Access and Reimbursement of Drugs

The United Kingdom Alzheimer's Disease Medication Market

  • The United Kingdom-Market Engineering Measurements
  • The United Kingdom-Revenue Forecast
  • Regulatory Framework - Treatment Access and Reimbursement of Drugs

Italian Alzheimer's Disease Medication Market

  • Italy-Market Engineering Measurements
  • Italy-Revenue Forecast
  • Regulatory Framework - Treatment Access and Reimbursement of Drugs

Spanish Alzheimer's Disease Medication Market

  • Spain-Market Engineering Measurements
  • Spain-Revenue Forecast
  • Regulatory Framework - Treatment Access and Reimbursement of Drugs

The Last Word

  • The Last Word -Three Big Predictions

Appendix

  • Market Engineering Methodology
  • List of Key European Alzheimer's Disease Networking Organisations
  • Additional Sources of Information Related to Alzheimer's Disease Medication Market
  • Table of Acronyms Used
  • Database of Key Industry Participants
  • Decision Support Databases
Show More
Pricing